Our results demonstrate that specific EV RNAs, such as miR−141, miR−375, and PCA3 lncRNA, are effective in distinguishing PCa from non-cancer controls and in stratifying patients by tumour grade and stage. The gene discussed is PCA3; the disease is posterior cortical atrophy.